Back
Akebia Therapeutics, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
21
AKBA
Akebia Therapeutics, Inc.
Last Price:
$1.36
Seasonality Move:
-12.3%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight selling pressure.
Akebia Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.43 | Sell |
| 20-day SMA: | 1.54 | Sell |
| 50-day SMA: | 1.64 | Sell |
| 200-day SMA: | 2.66 | Sell |
| 8-day EMA: | 1.42 | Sell |
| 20-day EMA: | 1.51 | Sell |
| 50-day EMA: | 1.75 | Sell |
| 200-day EMA: | 2.31 | Sell |
Akebia Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 32.37 | Sell |
| Chaikin Money Flow: | -922258 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.45 - 1.67) | Sell |
| Bollinger Bands (100): | (1.6 - 2.92) | Sell |
Akebia Therapeutics, Inc. Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics, Inc. Stock
Is Akebia Therapeutics, Inc. Stock a Buy?
-
Akebia Therapeutics, Inc. share price is 1.36 while AKBA 8-day simple moving average is 1.43, which is a Sell signal.
-
The stock price of AKBA is 1.36 while Akebia Therapeutics, Inc. 20-day SMA is 1.54, which makes it a Sell.
-
Akebia Therapeutics, Inc. 50-day simple moving average is 1.64 while AKBA share price is 1.36, making it a Sell technically.
-
AKBA stock price is 1.36 and Akebia Therapeutics, Inc. 200-day simple moving average is 2.66, creating a Sell signal.
AKBA Technical Analysis vs Fundamental Analysis
Sell
21
Akebia Therapeutics, Inc. (AKBA)
is a Sell
Is Akebia Therapeutics, Inc. a Buy or a Sell?
-
Akebia Therapeutics, Inc. stock is rated a SellThe current Akebia Therapeutics, Inc. [AKBA] share price is $1.36. The Score for AKBA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Akebia Therapeutics, Inc. Stock Info
Market Cap:
360.9M
Price in USD:
1.36
Share Volume:
2.8M
Akebia Therapeutics, Inc. 52-Week Range
52-Week High:
4.08
52-Week Low:
1.31
Sell
21
Akebia Therapeutics, Inc. (AKBA)
is a Sell
Akebia Therapeutics, Inc. Share Price Forecast
-
What is the Akebia Therapeutics, Inc. stock price today?The Akebia Therapeutics, Inc. stock price is 1.36 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics, Inc. is overvalued.
Is Akebia Therapeutics, Inc. Stock a Buy?
-
Akebia Therapeutics, Inc. share price is 1.36 while AKBA 8-day exponential moving average is 1.42, which is a Sell signal.
-
The stock price of AKBA is 1.36 while Akebia Therapeutics, Inc. 20-day EMA is 1.51, which makes it a Sell.
-
Akebia Therapeutics, Inc. 50-day exponential moving average is 1.75 while AKBA share price is 1.36, making it a Sell technically.
-
AKBA stock price is 1.36 and Akebia Therapeutics, Inc. 200-day simple moving average is 2.31, creating a Sell signal.
Fundamental Analysis of Akebia Therapeutics, Inc.
Is Akebia Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.04 per share.
Technical Analysis of Akebia Therapeutics, Inc.
Should I short Akebia Therapeutics, Inc. stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Akebia Therapeutics, Inc. is a Sell
-
Akebia Therapeutics, Inc. Relative Strength Index (RSI) is 32.37, which suggest Akebia Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Akebia Therapeutics, Inc. is (1.45 - 1.67), which suggest Akebia Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Akebia Therapeutics, Inc. is (1.6 - 2.92), which suggest Akebia Therapeutics, Inc. is a Sell
* Akebia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.